Phase IV, open-label, multicentre trial of afatinib in patients (pts) aged ≥70 yrs with NSCLC harbouring common (Del19/L858R) EGFR mutations: Preliminary results

K. L. Reckamp, P. Gilman, B. Halmos, M. Jahanzeb, J. McCann, H. Paripati, L. C. Seneviratne, J. A. Wallace, B. Rueter, A. Esler, E. Dowling, M. Koczywas

Research output: Contribution to journalArticlepeer-review

7 Scopus citations
Original languageEnglish (US)
Pages (from-to)viii527
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
StatePublished - Oct 1 2018

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this